Women's CKD Cases Triple Globally in Three Decades, Reveals Study
Increased Chronic Kidney Disease Cases in women
New Delhi: A new study led by researchers from the Gujarat Adani Institute of Medical Sciences (GAIMS) reveals that global cases of chronic kidney disease (CKD) among women have nearly tripled over the past three decades.
Research presented at the 'ASN Kidney Week 2024' in San Diego, held from October 23–27, identified type 2 diabetes and hypertension as the primary contributors to CKD-related deaths among women.
Senior author Dr Hardik Dineshbhai Desai, independent clinical and public health researcher at GAIMS, stated: "This calls for immediate policy interventions, targeted prevention programmes, and investment in health care infrastructure to curb the rise of CKD, particularly in high-risk regions."
The Gujarat Adani Institute of Medical Sciences (GAIMS) represents the first public-private partnership (PPP) initiative between the Gujarat government and the Adani Education and Research Foundation.
The analysis, titled Global, National, and Regional Trends in the "Burden of Chronic Kidney Disease among Women from 1990-2021: A Comprehensive Global Analysis", is based on data from the 2021 Global Burden of Disease study, which aims to measure health loss worldwide over time. It encompasses information from 204 countries and territories.
Between 1990 and 2021, the average annual percentage increase in chronic kidney disease (CKD) prevalence among women was 2.10%, while mortality rose by 3.39%, and disability-adjusted life years (DALYs) grew by 2.48%.
Significant disparities in chronic kidney disease (CKD)-related mortality and morbidity have emerged globally, with notable increases observed in Latin America, North America, and among older adults.
The study revealed a concerning rise in mortality rates linked to metabolic risk factors over the past decade, following a brief decline between 2000 and 2010.
Dr Desai said, “Public awareness campaigns about the importance of early diagnosis, healthy lifestyles, and the management of underlying conditions like diabetes and hypertension are critical.”
“Without swift action, the continued rise of CKD could overwhelm health care systems and lead to increased mortality and morbidity worldwide,” he further added.
(with inputs from IANS)